Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community
- 157 Downloads
To elucidate the factors associated with mortality rates among older subjects with hepatocellular carcinoma (HCC) and diabetes mellitus (DM) in a triple hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis delta virus (HDV) endemic community.
A total of 2,909 residents aged ≥45 years were screened for hepatitis B surface antigen (HBsAg), antibodies to HCV (anti-HCV) and alanine aminotransaminase (ALT) in 1997. Anti-HDV was detected in HBsAg-positive subjects. Those who expired from HCC and DM were identified from official mortality data sets (1997–2003). Survival was analyzed using the Kaplan–Meier survival curve with log-rank test and the Cox proportional hazard model.
Forty-one patients died of HCC and 25 of DM during the study period. Multivariate analysis indicated that age ≥65 years (hazard ratio 3.4; 95% confidence interval 1.8–6.4), HBsAg (3.3; 1.7–6.7), anti-HCV (3.8; 1.7–8.5) and ALT ≥40 IU/L (3.7; 1.9–7.0) were independent predictors of HCC mortality, while age ≥65 years (4.8; 2.1–11.0) and anti-HCV (4.2; 1.7–10.6) were two independent predictors of DM mortality. There were synergistic effects of dual viral infections for HCC, but not for DM mortality.
Old age and chronic HCV infection increase the risk of HCC and DM mortality. HBsAg and ALT levels are also risk factors for HCC mortality, but not DM. The synergistic effects of dual hepatitis viral infections are demonstrable and warrant further investigation.
KeywordsDiabetes mellitus Hepatitis B virus Hepatitis C virus Hepatocellular carcinoma Mortality
This study was supported by a grant to Dr. S.N. Lu from the National Science Council of the Republic of China (NSC 92-2314-B-182-065).
- 6.Kurbanov F, Tanaka Y, Elkady A, Oyunsuren T, Mizokami M. Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia. J Viral Hepat 2007;14:667–74.Google Scholar
- 11.Tzonou A, Trichopoulos D, Kaklamani E, Zavitsanos X, Koumantaki Y, Hsieh CC. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D virus, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer. 1991;49:377–80.CrossRefPubMedGoogle Scholar
- 20.Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev. 1996;5:173–8.PubMedGoogle Scholar
- 30.Taiwan Public Health Association. Taiwan Cancer Registry. Taipei: Taiwan Public Health Association. Available at: http://crs.cph.ntu.edu.tw/. Accessed 26 Feb 2007.
- 32.Cheng DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990;162:817–22.Google Scholar
- 47.Lu SN, Wang JH, Kuo YK, Kuo HL, Chen TM, Tung HD, et al. Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: a method to identify areas endemic for HCV. Am J Trop Med Hyg. 2002;67:145–50.PubMedGoogle Scholar
- 58.Chen IL, Lu SN, Wu CL. HBsAg and anti-HCV prevalence among villages in an endemic township: a community study in Tzukuan, Kaohsiung. Chin J Public Health. 1999;18:313–8.Google Scholar